News
Health agency warns of link between pregnancy complications and weight loss drugs
Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, Zepbound, and Mounjaro. A UK health agency warns that these drugs could lead to unintended pregnancies and complications during pregnancy.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Zepbound was found to be more effective. Study participants using tirzepatide lost more weight after 72 weeks (average loss of 20.2% compared to 13.7% for semaglutide). This translates to an ...
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback